Edgewell Personal Care Q1 2026 Earnings Call Insights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy EPC?
Source: seekingalpha
- Strategic Transformation Progress: Edgewell completed the sale of its Feminine Care business, calling it a pivotal step in its transformation journey, which sharpens focus on core categories like Shave, Sun, Skin Care, and Grooming, enhancing competitive advantages and market momentum.
- Strong North American Performance: While organic net sales decreased by 50 basis points overall, North America outperformed expectations, particularly with earlier-than-anticipated Sun Care orders, indicating strong growth potential in the region.
- Stable Financial Outlook: The company projects adjusted EPS for fiscal 2026 to be between $1.70 and $2.10, with organic net sales growth expected to range from down 1% to up 2%, reflecting confidence in future performance.
- Cost Control and Profitability: Despite a 210 basis point decline in adjusted gross margin rate, Edgewell offset some cost pressures with 240 basis points of productivity savings, demonstrating effective cost management strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EPC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EPC
Wall Street analysts forecast EPC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EPC is 23.60 USD with a low forecast of 19.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 20.750
Low
19.00
Averages
23.60
High
32.00
Current: 20.750
Low
19.00
Averages
23.60
High
32.00
About EPC
Edgewell Personal Care Company is a manufacturer and marketer of personal care products. With operations in approximately 20 countries, its products are widely available in more than 50 countries. The Company has three segments: Wet Shave, Sun and Skin Care, and Feminine Care. The Wet Shave segment consists of products sold under the Schick, Wilkinson Sword, Edge, Skintimate, Billie, Shave Guard and its custom brands group, as well as non-branded products. The Company’s Wet Shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. The Sun and Skin Care segment products are sold under the Banana Boat, Hawaiian Tropic, Bulldog, Jack Black, Cremo and Wet Ones brand names. Feminine Care markets products under the Playtex, Stayfree, Carefree and o.b. brands. It offers tampons under the Playtex Gentle Glide 360, Playtex Sport, Playtex and o.b. brands. It also markets pads and liners under the Stayfree and Carefree brands.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Edgewell Personal Care Q1 2026 Earnings Call Insights
- Strategic Transformation Progress: Edgewell completed the sale of its Feminine Care business, calling it a pivotal step in its transformation journey, which sharpens focus on core categories like Shave, Sun, Skin Care, and Grooming, enhancing competitive advantages and market momentum.
- Strong North American Performance: While organic net sales decreased by 50 basis points overall, North America outperformed expectations, particularly with earlier-than-anticipated Sun Care orders, indicating strong growth potential in the region.
- Stable Financial Outlook: The company projects adjusted EPS for fiscal 2026 to be between $1.70 and $2.10, with organic net sales growth expected to range from down 1% to up 2%, reflecting confidence in future performance.
- Cost Control and Profitability: Despite a 210 basis point decline in adjusted gross margin rate, Edgewell offset some cost pressures with 240 basis points of productivity savings, demonstrating effective cost management strategies.
See More
Edgewell (EPC) Q1 2026 Earnings Call Transcript
See More
EDGEWELL PERSONAL CARE STOCK FALLS 7.7% FOLLOWING CUT IN ANNUAL PROFIT OUTLOOK
Personal Care Shares Decline: Personal care shares have dropped by 7.7% following recent cuts in forecasts.
Annual Profit Forecast Adjustments: The adjustments in profit forecasts have led to a reevaluation of the financial outlook for the sector.
See More
Edgewell Declares Quarterly Dividend of $0.15 per Share
- Quarterly Dividend Declaration: Edgewell has declared a quarterly dividend of $0.15 per share, consistent with previous distributions, demonstrating the company's ongoing ability to maintain stable cash flow, which is likely to attract income-seeking investors.
- Dividend Yield: The forward yield of 2.89% reflects the company's attractiveness in the current market environment, potentially increasing investor interest in Edgewell's stock.
- Dividend Payment Dates: The dividend is payable on April 8, with a record date of March 6 and an ex-dividend date also on March 6, providing investors with a clear timeline for their investment decisions.
- Future Outlook: Edgewell's FY26 outlook projects organic net sales growth targets ranging from a decline of 1% to an increase of 2%, indicating a cautious approach in the face of market challenges while divesting feminine care products to optimize its business structure.
See More
Edgewell Q1 Earnings Beat Expectations, Cautious Outlook Ahead
- Earnings Beat: Edgewell reported Q1 non-GAAP EPS of $0.03, exceeding expectations by $0.19, with revenue of $486.8 million reflecting a 1.8% year-over-year increase, surpassing estimates by $9.12 million, indicating resilience in a challenging market.
- Core Operations Performance: Continuing operations, excluding the Feminine Care business, generated net sales of $422.8 million, up 1.9% year-over-year, although organic net sales fell by 0.5%, highlighting external market pressures impacting sales.
- Cautious Outlook: The company expects reported net sales to grow between 0.5% and 3.5%, with organic net sales anticipated to range from a 1% decline to a 2% increase, reflecting uncertainty in future market conditions, particularly post-divestiture of the Feminine Care segment.
- Financial Metrics Adjustments: GAAP EPS is projected between $0.55 and $0.95, while adjusted EPS is expected to range from $1.70 to $2.10, reflecting significant impacts from the Feminine Care divestiture, with adjusted EBITDA forecasted between $245 million and $265 million, indicating challenges in cost management.
See More
Edgewell Exceeds Q1 Expectations with Strategic Divestiture
- Performance Exceeds Expectations: Edgewell reported net sales of $422.8 million for Q1 2026, reflecting a 1.9% increase, bolstered by a favorable currency impact of $9.6 million, demonstrating strong execution in core business areas.
- Strategic Divestiture: The successful divestiture of the Feminine Care business for $340 million not only sharpens the company's portfolio focus but also strengthens its balance sheet, laying a solid foundation for future sustainable growth.
- Adjusted Financial Outlook: After adjusting for the divestiture's impact, Edgewell's full-year outlook for continuing operations remains unchanged, with expectations for sales, adjusted EPS, and free cash flow consistent with prior forecasts, indicating stability during the transformation process.
- Cost Efficiency Improvements: The company recorded $24.4 million in restructuring charges in Q1, aimed at enhancing operational efficiency and effectiveness, which is expected to positively influence future financial performance.
See More
Edgewell Personal Care Q1 2026 Earnings Call Insights
- Strategic Transformation Progress: Edgewell completed the sale of its Feminine Care business, calling it a pivotal step in its transformation journey, which sharpens focus on core categories like Shave, Sun, Skin Care, and Grooming, enhancing competitive advantages and market momentum.
- Strong North American Performance: While organic net sales decreased by 50 basis points overall, North America outperformed expectations, particularly with earlier-than-anticipated Sun Care orders, indicating strong growth potential in the region.
- Stable Financial Outlook: The company projects adjusted EPS for fiscal 2026 to be between $1.70 and $2.10, with organic net sales growth expected to range from down 1% to up 2%, reflecting confidence in future performance.
- Cost Control and Profitability: Despite a 210 basis point decline in adjusted gross margin rate, Edgewell offset some cost pressures with 240 basis points of productivity savings, demonstrating effective cost management strategies.
See More
Edgewell (EPC) Q1 2026 Earnings Call Transcript
See More
EDGEWELL PERSONAL CARE STOCK FALLS 7.7% FOLLOWING CUT IN ANNUAL PROFIT OUTLOOK
Personal Care Shares Decline: Personal care shares have dropped by 7.7% following recent cuts in forecasts.
Annual Profit Forecast Adjustments: The adjustments in profit forecasts have led to a reevaluation of the financial outlook for the sector.
See More
Edgewell Declares Quarterly Dividend of $0.15 per Share
- Quarterly Dividend Declaration: Edgewell has declared a quarterly dividend of $0.15 per share, consistent with previous distributions, demonstrating the company's ongoing ability to maintain stable cash flow, which is likely to attract income-seeking investors.
- Dividend Yield: The forward yield of 2.89% reflects the company's attractiveness in the current market environment, potentially increasing investor interest in Edgewell's stock.
- Dividend Payment Dates: The dividend is payable on April 8, with a record date of March 6 and an ex-dividend date also on March 6, providing investors with a clear timeline for their investment decisions.
- Future Outlook: Edgewell's FY26 outlook projects organic net sales growth targets ranging from a decline of 1% to an increase of 2%, indicating a cautious approach in the face of market challenges while divesting feminine care products to optimize its business structure.
See More
Edgewell Q1 Earnings Beat Expectations, Cautious Outlook Ahead
- Earnings Beat: Edgewell reported Q1 non-GAAP EPS of $0.03, exceeding expectations by $0.19, with revenue of $486.8 million reflecting a 1.8% year-over-year increase, surpassing estimates by $9.12 million, indicating resilience in a challenging market.
- Core Operations Performance: Continuing operations, excluding the Feminine Care business, generated net sales of $422.8 million, up 1.9% year-over-year, although organic net sales fell by 0.5%, highlighting external market pressures impacting sales.
- Cautious Outlook: The company expects reported net sales to grow between 0.5% and 3.5%, with organic net sales anticipated to range from a 1% decline to a 2% increase, reflecting uncertainty in future market conditions, particularly post-divestiture of the Feminine Care segment.
- Financial Metrics Adjustments: GAAP EPS is projected between $0.55 and $0.95, while adjusted EPS is expected to range from $1.70 to $2.10, reflecting significant impacts from the Feminine Care divestiture, with adjusted EBITDA forecasted between $245 million and $265 million, indicating challenges in cost management.
See More
Edgewell Exceeds Q1 Expectations with Strategic Divestiture
- Performance Exceeds Expectations: Edgewell reported net sales of $422.8 million for Q1 2026, reflecting a 1.9% increase, bolstered by a favorable currency impact of $9.6 million, demonstrating strong execution in core business areas.
- Strategic Divestiture: The successful divestiture of the Feminine Care business for $340 million not only sharpens the company's portfolio focus but also strengthens its balance sheet, laying a solid foundation for future sustainable growth.
- Adjusted Financial Outlook: After adjusting for the divestiture's impact, Edgewell's full-year outlook for continuing operations remains unchanged, with expectations for sales, adjusted EPS, and free cash flow consistent with prior forecasts, indicating stability during the transformation process.
- Cost Efficiency Improvements: The company recorded $24.4 million in restructuring charges in Q1, aimed at enhancing operational efficiency and effectiveness, which is expected to positively influence future financial performance.
See More
